1 Tuberculosis K. Brat Dept. of Respiratory Diseases, Faculty of Medicine and University Hospital Brno 2 nTuberculosis n n nInfectious disease caused by M. tuberculosis, M. africanum, M. bovis, M. BCG, M. microti, M. canetti , M. caprae. M. pinnipedii nM.bovis eradicated in the 1960s nLungs – most frequently affected organ (80 - 90%) n= most frequent type of transmission is by coughing nOther organs include the kidneys, bones, urogenital organs, intestine 3 TB in the Czech Rep. and in the world n n10.4 million TB cases worldwide (in 2016) n1.9 billion people infected (= latent TB infection) n1.7 million deaths worldwide in 2016 (0.25 million children) n nIn the Czech Rep.: incidence 4.9 cases/100 000 persons (2016) = ca 510 cases nPersons at higher risk of TB: HIV-positive, immigrants, homeless 4 n Clinical symptoms of TB n nChronic cough (4 and more weeks) nChest pain nWeight loss, anorexia nFatigue nHemopytsis nNight sweat and fevers nContact with an infected person nCXR finding compatible with TB diagnosis 5 Forms of TB n nPrimary TB n nPost-primary TB (progression of latent TB) – in chronic diseases, malignancies, older age n nSecondary TB (infection by other TB strain) n 6 Diagnosis n n nAnamnesis nEpidemiology nCXR finding nTuberculin skin test nBacteriology (sputum, bronchoalveolar lavage fluid, other) nHistology 7 TB – upper lobes (typical) 12 22 8 TB pleurisy x4 x1 9 TB pleurisy and pulmonary TB Pa010805 Pa010810 10 Miliary TB n 11 Pulmonary TB – less typical forms 17 28 12 Complicated TB 24 n 13 nBacteriology - methods n nMicroscopy nCultivation – 6 weeks! nRapis bacteriology tests – detection of metabolic activity of M.tuberculosis : Bactec and MGIT tests – 10-14 days nPCR method 14 HISTORY OF TB TREATMENT nUntil 1882: climatotherapy n nSince 1882: iatrogenic pneumothorax, thoracic surgery n nMortality of untreated TB: ca 50% n nIn the 1940s and 50s: discovery of antituberculotic drugs (ATDs) n nSince 1970s: WHO-recommended treatment regimen: Directly Observed Treatment Short-Course = DOTS n 15 Phases of TB treatment n nIntensive phase (initial) – 2 months, usually hospitalization: 4-combination of 1st class ATDs n= combined of INH,RMP,PZA,EMB n nContinuation phase – 4 months, usually outpatient care n= combined of INH+RMP n n TB in the world n>80% of cases occur in 8 countries (India, Indonesia, China, Pakistan, Bangladesh, The Philippines, RSA, Nigeria) nHighest incidence rate in the world (2017): Lesotho, Eswatini and RSA nHighest incidence rate in Europe: Greenland and Republic of Moldova nHighest incidence rates – other continents: Bolivia, Haiti, Mexico, Vanuatu 16 Be aware of… nCoincidence of TBC and HIV n40% of HIV-related deaths are caused by TB nIncreasing rate of drug-resistant forms worldwide nMDR-TB: resistance to RMP+INH (ca 0.5mil.cases reported in 2017 worldwide) nXDR-TB: res.to RMP+INH+fluoroqinolone+aminoglycoside nTDR-TB: resistance to all first-class drugs + a number of ATDs of the 2nd to 5th classes 17